Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,540,233
-$426,013 QoQ
Shares Held
185,347
-0.1% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 198 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. ARVN ranks #138 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in ARVN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,540,233 | 185,347 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,966,246 | 185,495 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $449,150 | 37,871 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $321,723 | 37,761 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $283,404 | 38,506 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $2,233,553 | 116,513 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,389,306 | 97,008 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,519,795 | 94,658 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,070,942 | 74,393 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,044,810 | 73,975 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,154,537 | 58,785 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,343,382 | 54,125 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,861,338 | 68,131 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $1,603,730 | 46,879 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,270,502 | 51,034 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,922,124 | 45,667 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,685,943 | 39,910 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,905,456 | 35,372 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,359,764 | 40,883 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,889,964 | 37,532 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,270,137 | 34,344 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,590,755 | 42,279 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $957,550 | 40,557 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $690,755 | 20,595 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||